SureTrader SPDR Advertisement
Home > Boards > US Listed > Medical - Drugs >

Arbutus Biopharma Corporation (ABUS)

Add ABUS Price Alert      Hide Sticky   Hide Intro
Moderator: No Moderator mick, nanopatent, KarinCA
Search This Board:
Last Post: 8/25/2015 1:03:51 PM - Followers: 111 - Board type: Free - Posts Today: 0

Arbutus Biopharma Corporation







Company Information:

100 - 8900 Glenlyon Parkway
Burnaby, British Columbia
Canada V5J 5J8

Telephone: 604.419.3200
Fax: 604.419.3201


As the fields of genetics, medicine and therapeutics continue to converge, the management of illness at its genetic source by silencing genes via RNA interference (RNAi) holds the very real potential to revolutionize treatment on a scale not seen in decades. Tekmira is one of a handful of biotech companies around the world working to exploit the potential of RNAi to treat disease. And it is from among these unique companies that the next wave of therapeutic breakthroughs will emerge.

 Tekmira is uniquely equipped to become a leading force in the field. Guided by a cohesive vision, the company possesses leading technology capabilities and a solid intellectual property portfolio in the area of lipid-based nucleic acid delivery, known as SNALP (Stable Nucleic Acid Lipid Particles) to deliver siRNAs (small interfering RNAs) as well as other oligonucleotides in the treatment of disease.

With one RNAi drug candidate in clinical development and another in late preclinical development,  plus a pipeline of up to five additional targets made possible through an agreement with RNAi leader Alnylam, Tekmira is well positioned to aggressively advance its product development strategy. In addition to Alnylam, Roche, Merck and Regulus all have access to Tekmira's technology in the delivery of siRNAs and microRNAs.

Finally, broad manufacturing capabilities and a strong capital position permit the company to move forward decisively and build a solid base for both near and longer term growth.




Important Company Highlights: 

LNP Delivery Platform

Tekmira’s Lipid Nanoparticle (LNP) technology represents the most widely adopted RNAi delivery technology to date. Administered intravenously, our LNP delivery technology allows RNAi drugs to be encapsulated in tiny particles made of lipids (fats or oils). These tiny particles – LNP – travel through the bloodstream to target tissues.





Recent News:





Links of importance for those that trade Canadian stocks:




 CNW Group Newswire:

Canadian Insider:

Currency Converter:


Transfer Agent:

CIBC Mellon Trust,
Suite 1600, The Oceanic Plaza,
1066 West Hastings Street,
Vancouver, BC V6E 3X1

Share Structure:   See filings

Investor Relations:

Ian Mortimer
Executive Vice President, Finance and Chief Financial Officer
Telephone: 604.419.3200
Fax: 604.419.3201

Adam Peeler
Investor Relations
The Equicom Group
Telephone: 416.815.0700 x 225 

 Currency Converter:

Five Year Weekly Chart





 All messages, including iBox content, are the opinion of the posters, are no substitute for your own research, and should not be relied upon for stock trading or any other purpose.

 Also, keep in mind that moderators may or may not have a position in said stock.  Being a moderator isn't a sign of endorsement.

 Please keep your posts on topic because your message(s) will probably be deleted when:
* Posting content that's off-topic to the subject of this board;
* Posting statements that don't add value to the discussion; or
* When you violate any other posting term of the iHub User Agreement:


  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
Current Price
Bid Ask Day's Range
ABUS News: Statement of Changes in Beneficial Ownership (4) 08/26/2015 01:30:49 PM
ABUS News: Amended Statement of Beneficial Ownership (sc 13d/a) 08/26/2015 06:02:52 AM
ABUS News: Current Report Filing (8-k) 08/25/2015 08:01:20 AM
ABUS News: Quarterly Report (10-q) 08/07/2015 06:33:58 PM
ABUS News: Current Report Filing (8-k) 08/07/2015 08:51:06 AM
#4953  Sticky Note NEW COMPANY NAME/ ARBUTUS BIOPHARMA CORPORATION/ $ABUS recent news/filings[/b mick 08/06/15 01:42:07 PM
#4964 mick 08/25/15 01:03:51 PM
#4963   Haven't played any otc stocks for a long rivervalley 08/20/15 03:28:50 PM
#4962   ABUS can bottom any time now..... rivervalley 08/17/15 10:08:37 AM
#4961 mick 08/08/15 05:39:05 PM
#4960   Nano patent Would you tell that to the Marines? Echo20 Echo20 08/07/15 03:40:45 PM
#4959   Is this heading for $1.22? Rawnoc 08/07/15 02:43:13 PM
#4957   I think that Ebola stuff was a dud nanopatent 08/07/15 01:06:29 PM
#4956   Nano patent Tkmr could have done the RING approach. Maybe Echo20 08/07/15 12:38:57 PM
#4955   make that 3,000 now at 10.20 :) rivervalley 08/06/15 04:15:15 PM
#4954   a couple thousand shares at 10.20 in ah session. rivervalley 08/06/15 04:14:26 PM
#4953   NEW COMPANY NAME/ ARBUTUS BIOPHARMA CORPORATION/ $ABUS recent news/filings[/b mick 08/06/15 01:42:07 PM
#4952   ONE RECENT CASE YESTERDAY/ EBOLA mick 08/06/15 01:34:07 PM
#4951 mick 08/06/15 01:32:05 PM
#4950   Yup - new name, new products, new strategy. nanopatent 08/05/15 02:00:25 PM
#4949   Nano patent Arbutus? Echo20 Echo20 08/05/15 12:53:34 PM
#4948   picked up a few 10.50's today on the rivervalley 08/04/15 02:18:07 PM
#4947   some nice buys rolling in now. rivervalley 08/04/15 11:22:50 AM
#4946   Tekmira name and symbol change effective today KarinCA 08/03/15 10:57:45 AM
#4945   Confidential Treatment Order (ct Order) nanopatent 07/31/15 01:09:07 PM
#4944   green start to the day. Hope it continues rivervalley 07/31/15 10:21:24 AM
#4943   Sadly no mention of TKM Ebola Ron1303 07/31/15 08:15:01 AM
#4942 mick 07/28/15 12:44:50 PM
#4941   Yesterday we hit $10.02 & with that the Ron1303 07/23/15 12:50:01 PM
#4940   Nice start to the day, let's see if rivervalley 07/23/15 10:33:06 AM
#4939   let's see if the 10.00 area which shows rivervalley 07/22/15 01:13:15 PM
#4938   MACD remains neutral & hardly registers the neg Ron1303 07/22/15 11:50:59 AM
#4937   We are doing great! As stated, institutions can Ron1303 07/22/15 10:02:12 AM
#4936   These guys sure talk like they have HBV nanopatent 07/20/15 09:52:50 AM
#4935   Analysts Set Tekmira Pharmaceuticals Corp Price Target at nanopatent 07/17/15 10:06:47 AM
#4934   Thin traded stocks are easier to manipulate. thuber 07/17/15 07:25:41 AM
#4933   Aprox. 30$ MM TKMR market cap were destroyed Ron1303 07/15/15 12:15:23 PM
#4932   knocking on the door of 12.00 which would rivervalley 07/13/15 01:27:01 PM
#4931   The military doesn't waste it, congress does. thuber 07/12/15 05:12:01 AM
#4930   Reminds me of the hammer the DoD ordered nanopatent 07/11/15 12:17:28 PM
#4929   Too funny. I've been in the army, the medic11 07/11/15 10:56:23 AM
#4928,uu[900,a]decly[dk][pb200!b300!b400!b50 mick 07/09/15 10:36:44 PM
#4927   DoD is not in the habit of advancing nanopatent 07/09/15 04:18:15 PM
#4926   I disagree with Calaverascounty @ Investor Village. He Ron1303 07/09/15 02:29:49 PM
#4925   Tekmira Pharmaceuticals Corp Analyst Price Target Update nanopatent 07/09/15 09:24:29 AM
#4924   ......a trend remains a trend until it is wsgalvanize 07/01/15 03:25:57 PM
#4923   Tekmira Pharmaceutic (TKMR) mick 07/01/15 03:20:55 PM
#4922 that doesn't look good at all...thanks for wsgalvanize 07/01/15 01:20:19 PM
#4921 mick 06/30/15 06:48:44 PM
#4920   IMO there are investors, related or not to Ron1303 06/26/15 10:47:11 AM
#4919 thuber 06/26/15 12:40:17 AM
#4918   Just for the hellovit I looked up Tekmira's nanopatent 06/23/15 01:38:15 PM
#4917   Even when there was a lot less doubt Ron1303 06/23/15 01:24:52 PM
#4916   You know what the main killer of a nanopatent 06/23/15 12:53:46 PM
#4915   I don´t think TKMR management is "confused". Ron1303 06/23/15 11:02:12 AM
#4914   I always expect management to know much more nanopatent 06/22/15 11:00:05 PM